Aperio Will Bring Together a Panel of Experts at LaunchBio to Discuss Preparing for Medical Device Trials

Panel Presentation Will Feature Top Medical Device Experts from Aperio Clinical Outcomes, JD Lymon Group, Brooks Medtech, LLC, and NuPulseCV, Inc.  

Aperio Clinical Outcomes, a clinical development organization headquartered in Morrisville, NC, will moderate a panel presentation titled “Begin With the End in Mind: Preparing for Your Medical Device Clinical Trial” at LaunchBio, Inc. on Thursday, November 7, 2019.

Whether it is to support a Premarket Approval (PMA), 510(k), or post-market strategies, your clinical trial is a crucial next step in the life of your medical device. Understanding the multiple facets necessary to consider in the clinical development process will provide you with a holistic view of the road ahead, and allow for realistic short- and long-term planning for your device development and commercialization.

Join our presentation and hear from a panel of industry experts in medtech development as we discuss what to keep in mind when moving towards a medical device clinical trial, including:

  • Regulatory pathways
  • Reimbursement planning
  • Study design considerations
  • Operationalizing your clinical trial

The panel is scheduled to take place from 4:15 – 5:15 pm at the Chesterfield Building in downtown Durham and will include a Q&A time with the panelists and ample networking opportunities afterward in the main room. Cari Kniola, Director of Corporate Strategy at Aperio Clinical Outcomes, will moderate our distinguished line-up of panelists:

Chris Lyle, MS
Partner
JD Lymon Group

Steven Brooks, MD, MBA, FACC
Principal
Brooks Medtech, LLC

Sonna Patel-Raman, PhD
President
NuPulseCV, Inc.

LaunchBio takes place from 4:00 – 7:00 pm at The Chesterfield in downtown Durham. Aperio’s panel is scheduled for 4:15 – 5:15 pm.

To learn more or to register to attend LaunchBio, click here.